Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPTAC trial of tranexamic acid for prevention of blood loss in cesarean delivery
ISRCTN11204890Phase 2Completed
- Sponsor
- Irrua Specialist Teaching Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in obstetric bleeding comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Blood loss at cesarean section and within 24 hours after surgery. Started Apr 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
obstetric bleeding
Beyond the preview
Go deeper on ISRCTN11204890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11204890.